472 related articles for article (PubMed ID: 11740733)
1. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
[TBL] [Abstract][Full Text] [Related]
4. [Immunogenicity of Staphylococcus aureus recombinant clumping factor A].
Feng H; Liu L; Chi J; Wang N; Li R; Tong C; Ma J; Zhu Z; Cui Y
Sheng Wu Gong Cheng Xue Bao; 2009 Aug; 25(8):1180-6. PubMed ID: 19938455
[TBL] [Abstract][Full Text] [Related]
5. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
Schennings T; Farnebo F; Szekely L; Flock JI
APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
[TBL] [Abstract][Full Text] [Related]
6. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
7. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus.
Nour El-Din AN; Shkreta L; Talbot BG; Diarra MS; Lacasse P
Vaccine; 2006 Mar; 24(12):1997-2006. PubMed ID: 16426711
[TBL] [Abstract][Full Text] [Related]
8. Construction and immunogenicity of a DNA vaccine containing clumping factor A of Staphylococcus aureus and bovine IL18.
Yin RL; Li C; Yang ZT; Zhang YJ; Bai WL; Li X; Yin RH; Liu H; Liu S; Yang Q; Cao YG; Zhang NS
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):270-4. PubMed ID: 19540000
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
[TBL] [Abstract][Full Text] [Related]
10. The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis.
Josefsson E; Juuti K; Bokarewa M; Kuusela P
Infect Immun; 2005 May; 73(5):2812-7. PubMed ID: 15845485
[TBL] [Abstract][Full Text] [Related]
11. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
13. Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletion.
Palmqvist N; Josefsson E; Tarkowski A
Microbes Infect; 2004 Feb; 6(2):196-201. PubMed ID: 14998518
[TBL] [Abstract][Full Text] [Related]
14. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
Therrien R; Lacasse P; Grondin G; Talbot BG
Vaccine; 2007 Jun; 25(27):5053-61. PubMed ID: 17532546
[TBL] [Abstract][Full Text] [Related]
15. In vivo sortase A and clumping factor A mRNA expression during Staphylococcus aureus infection.
Josefsson E; Kubica M; Mydel P; Potempa J; Tarkowski A
Microb Pathog; 2008 Feb; 44(2):103-10. PubMed ID: 17890045
[TBL] [Abstract][Full Text] [Related]
16. Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies.
Scarpa M; Piccinini R; Brun P; Grillo A; Palù G; Mengoli C; Daprà V; Castagliuolo I; Zecconi A
J Dairy Res; 2010 May; 77(2):159-67. PubMed ID: 20030902
[TBL] [Abstract][Full Text] [Related]
17. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleotide reductase class III, an essential enzyme for the anaerobic growth of Staphylococcus aureus, is a virulence determinant in septic arthritis.
Kirdis E; Jonsson IM; Kubica M; Potempa J; Josefsson E; Masalha M; Foster SJ; Tarkowski A
Microb Pathog; 2007; 43(5-6):179-88. PubMed ID: 17606358
[TBL] [Abstract][Full Text] [Related]
19. Expression of staphylococcal clumping factor A impedes macrophage phagocytosis.
Palmqvist N; Patti JM; Tarkowski A; Josefsson E
Microbes Infect; 2004 Feb; 6(2):188-95. PubMed ID: 14998517
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.
Hall AE; Domanski PJ; Patel PR; Vernachio JH; Syribeys PJ; Gorovits EL; Johnson MA; Ross JM; Hutchins JT; Patti JM
Infect Immun; 2003 Dec; 71(12):6864-70. PubMed ID: 14638774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
